BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18651806)

  • 1. Accelerating Haemophilus influenzae type b vaccine introduction in the world's poorest countries: a dream is coming true.
    O'Loughlin RE; Hajjeh R
    Future Microbiol; 2008 Aug; 3(4):377-8. PubMed ID: 18651806
    [No Abstract]   [Full Text] [Related]  

  • 2. The impact of vaccines on pneumonia: key lessons from Haemophilus influenzae type b conjugate vaccines.
    Gessner BD; Adegbola RA
    Vaccine; 2008 Jun; 26 Suppl 2():B3-8. PubMed ID: 18793604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Forecasting demand for Hib-containing vaccine in the world's poorest countries: a 4-year prospective experience.
    Zuber PL; Dumolard L; Shirey M; Rizzo I; Marshall J
    Vaccine; 2009 Jan; 27(3):410-5. PubMed ID: 19013493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global use of Haemophilus influenzae type b conjugate vaccine.
    Ojo LR; O'Loughlin RE; Cohen AL; Loo JD; Edmond KM; Shetty SS; Bear AP; Privor-Dumm L; Griffiths UK; Hajjeh R
    Vaccine; 2010 Oct; 28(43):7117-22. PubMed ID: 20691265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemophilus influenzae serotype b vaccine failure: what is the significance of antibody levels?
    Spanjaard L; Rijkers GT
    Clin Infect Dis; 2009 Aug; 49(3):381-2. PubMed ID: 19580417
    [No Abstract]   [Full Text] [Related]  

  • 6. Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa.
    Gessner BD
    Expert Rev Vaccines; 2009 Jan; 8(1):91-102. PubMed ID: 19093776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Foresight in medicine: current challenges with Haemophilus influenzae type b conjugate vaccines.
    Eskola J
    J Intern Med; 2010 Mar; 267(3):241-50. PubMed ID: 20201918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophilus influenzae serotype b conjugate vaccine failure in twelve countries with established national childhood immunization programmes.
    Ladhani S; Heath PT; Slack MP; McIntyre PB; Diez-Domingo J; Campos J; Dagan R; Ramsay ME;
    Clin Microbiol Infect; 2010 Jul; 16(7):948-54. PubMed ID: 19889054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toward global Haemophilus influenzae type b immunization.
    Dominguez SR; Daum RS
    Clin Infect Dis; 2003 Dec; 37(12):1600-2. PubMed ID: 14689338
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of functional Haemophilus influenzae type b antibodies after vaccination.
    van der Velden AM; Claessen AM; van Velzen-Blad H; Biesma DH; Rijker GT
    Haematologica; 2005 Nov; 90(11):1582-4. PubMed ID: 16266910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007.
    Scheifele DW; Bettinger JA; Halperin SA; Law B; Bortolussi R
    Pediatr Infect Dis J; 2008 Aug; 27(8):755-7. PubMed ID: 18594482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilus influenzae type b disease among children in rural Mozambique: impact of vaccine introduction.
    Sigaúque B; Vubil D; Sozinho A; Quintó L; Morais L; Sacoor C; Carvalho MG; Verani JR; Alonso PL; Roca A
    J Pediatr; 2013 Jul; 163(1 Suppl):S19-24. PubMed ID: 23773589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hib immunisation catch up programme in North East Thames.
    O'Brien H
    Commun Dis Rep CDR Rev; 1994 Feb; 4(2):R17-8. PubMed ID: 7511460
    [No Abstract]   [Full Text] [Related]  

  • 14. Supporting new vaccine introduction decisions: lessons learned from the Hib Initiative experience.
    Hajjeh RA; Privor-Dumm L; Edmond K; O'Loughlin R; Shetty S; Griffiths UK; Bear AP; Cohen AL; Chandran A; Schuchat A; Mulholland EK; Santosham M
    Vaccine; 2010 Oct; 28(43):7123-9. PubMed ID: 20659515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Worldwide introduction and coverage of Haemophilus influenzae type b conjugate vaccine.
    O'Loughlin R; Hajjeh R;
    Lancet Infect Dis; 2008 Dec; 8(12):736. PubMed ID: 19022186
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacteria, polysaccharides, vaccines and boosting: measuring and maintaining population immunity.
    Goldblatt D
    Arch Dis Child; 2008 Aug; 93(8):646-7. PubMed ID: 18644932
    [No Abstract]   [Full Text] [Related]  

  • 17. Progress introducing Haemophilus influenzae type b vaccine in low-income countries, 2004-2008.
    Wkly Epidemiol Rec; 2008 Feb; 83(7):61-7. PubMed ID: 18283719
    [No Abstract]   [Full Text] [Related]  

  • 18. [Global challenges of Haemophilus vaccinations quarter of a century after the Hib project].
    Eskola J; Black S
    Duodecim; 2010; 126(9):1047-54. PubMed ID: 20593628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemophilus influenzae: capsule vaccine and capsulation genetics.
    Kroll JS; Booy R
    Mol Med Today; 1996 Apr; 2(4):160-5. PubMed ID: 8796878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Haemophilus influenzae type b (Hib) vaccine: an effective control strategy in India.
    Verma R; Khanna P; Chawla S; Bairwa M; Prinja S; Rajput M
    Hum Vaccin; 2011 Nov; 7(11):1158-60. PubMed ID: 22048118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.